AU2003277988A1 - Therapeutic compounds and methods - Google Patents
Therapeutic compounds and methods Download PDFInfo
- Publication number
- AU2003277988A1 AU2003277988A1 AU2003277988A AU2003277988A AU2003277988A1 AU 2003277988 A1 AU2003277988 A1 AU 2003277988A1 AU 2003277988 A AU2003277988 A AU 2003277988A AU 2003277988 A AU2003277988 A AU 2003277988A AU 2003277988 A1 AU2003277988 A1 AU 2003277988A1
- Authority
- AU
- Australia
- Prior art keywords
- optionally substituted
- compound
- compound according
- group
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/291,863 US6710075B2 (en) | 2000-07-05 | 2002-11-08 | Therapeutic compounds and methods |
| US10/291,863 | 2002-11-08 | ||
| PCT/AU2003/001463 WO2004041812A1 (en) | 2002-11-08 | 2003-11-06 | Therapeutic compounds and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003277988A1 true AU2003277988A1 (en) | 2004-06-07 |
Family
ID=32312131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003277988A Abandoned AU2003277988A1 (en) | 2002-11-08 | 2003-11-06 | Therapeutic compounds and methods |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1569928A4 (https=) |
| JP (1) | JP4847014B2 (https=) |
| AU (1) | AU2003277988A1 (https=) |
| CA (1) | CA2504999A1 (https=) |
| WO (1) | WO2004041812A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5249508B2 (ja) | 2006-11-06 | 2013-07-31 | 三菱重工業株式会社 | 軌道系交通システム |
| BR112013032306B1 (pt) | 2011-06-16 | 2021-05-25 | Korea Research Institute Of Chemical Technology | derivados de indanona, método de preparação dos mesmos, composições farmacêuticas e uso dos mesmos para prevenção ou tratamento de doenças virais |
| ES2863985T3 (es) | 2012-12-14 | 2021-10-13 | Korea Res Inst Chemical Tech | Nuevo compuesto, sal farmacéuticamente aceptable o isómero óptico del mismo, método para prepararlo y composición farmacéutica para la prevención o el tratamiento de enfermedades virales que lo contienen como ingrediente activo |
| WO2017214024A1 (en) | 2016-06-06 | 2017-12-14 | Genentech, Inc. | Silvestrol antibody-drug conjugates and methods of use |
| JP7592748B2 (ja) | 2020-04-20 | 2024-12-02 | ノバルティス アーゲー | 抗ウイルス1,3-ジ-オキソ-インデン化合物 |
| US12083092B2 (en) | 2020-04-20 | 2024-09-10 | Novartis Ag | Antiviral 1,3-di-oxo-indene compounds |
| CN115385924B (zh) * | 2022-10-06 | 2023-10-13 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种具有抗肿瘤活性的环戊烷苯并呋喃类化合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19835325A1 (de) * | 1998-08-05 | 2000-02-10 | Bayer Ag | Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten |
| AUPQ866500A0 (en) * | 2000-07-05 | 2000-08-03 | Exgenix Operations Pty Ltd | Therapeutic compounds and methods |
-
2003
- 2003-11-06 CA CA002504999A patent/CA2504999A1/en not_active Abandoned
- 2003-11-06 AU AU2003277988A patent/AU2003277988A1/en not_active Abandoned
- 2003-11-06 JP JP2004548931A patent/JP4847014B2/ja not_active Expired - Fee Related
- 2003-11-06 EP EP03769069A patent/EP1569928A4/en not_active Withdrawn
- 2003-11-06 WO PCT/AU2003/001463 patent/WO2004041812A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1569928A1 (en) | 2005-09-07 |
| WO2004041812A1 (en) | 2004-05-21 |
| JP4847014B2 (ja) | 2011-12-28 |
| JP2006508098A (ja) | 2006-03-09 |
| EP1569928A4 (en) | 2008-12-10 |
| CA2504999A1 (en) | 2004-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jim-Min et al. | Lignans from leaves of Juniperus chinensis | |
| Ebada et al. | Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae) | |
| Sumino et al. | Ardisiphenols and other antioxidant principles from the fruits of Ardisia colorata | |
| ITOKAWA et al. | New antitumor principles, casearins AF, for Casearia sylvestris Sw.(Flacourtiaceae) | |
| KR100357542B1 (ko) | 푸마질롤 유도체 및 그 제조방법 | |
| Liu et al. | Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui | |
| US6710075B2 (en) | Therapeutic compounds and methods | |
| FI70699B (fi) | Foerfarande foer framstaellning av antivirala substituerade actofenoner | |
| Li et al. | Synthesis and anti-tumor activity of nitrogen-containing derivatives of the natural product diphyllin | |
| Kouno et al. | Isolation of neoanisatin derivatives from the pericarps of Illicium majus with other constituents | |
| Sugawara et al. | Zearalenone derivatives produced by the fungus Drechslera portulacae | |
| Sun et al. | Three new cytotoxic aryltetralin lignans from Sinopodophyllum emodi | |
| AU2003277988A1 (en) | Therapeutic compounds and methods | |
| Jiang et al. | New amide alkaloids from Piper longum | |
| JP2004501983A5 (https=) | ||
| MIYASE et al. | Studies on the Constituents of Hedysarum polybotrys HAND.-MAZZ. | |
| CN109734759B (zh) | 一种梓醇衍生物及其应用 | |
| AU2001268848B2 (en) | Therapeutic compounds and methods | |
| Zhang et al. | Two new coumarins from Herpetospermum caudigerum | |
| CA2151635A1 (en) | Antitumoral Compounds | |
| Hu et al. | Synthesis and biological activity of amide derivatives of ginkgolide A | |
| AU2001268848A1 (en) | Therapeutic compounds and methods | |
| JP4769726B2 (ja) | コンセントリコリド及びその誘導体、それらを調製する工程、それを含む薬学的組成物並びにその使用 | |
| Cheng et al. | Two new diterpenoids from Mallotus apelta Muell. Arg. | |
| Lee et al. | Two new furanocoumarins from the roots of Angelica dahurica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |